HENRY SCHEIN INC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $HSIC in the last 7 days.
No SEC Form 4 filings for $HSIC in the last 30 days.
See all $HSIC insider activity →Henry Schein, Inc. (HSIC) reported broad-based growth in Q2, with sales increases across distribution, specialty products, and technology. Management raised its 2026 sales and earnings guidance. HSIC trades at a discount to market benchmarks but faces risks from leverage and execution challenges. The company aims for $200M in operating income improvement by 2026, with savings initiatives underway.
BTIG raised its price target on Henry Schein to $110 from $100 while maintaining a Buy rating. The stock is currently trading at $89.57, up 0.38% on the day but down 1.28% over the past year. Barclays also recently adjusted its target to $100 from $86.
Henry Schein (HSIC) reported Q2 2026 sales of $3,458 million and net income of $94 million, both up year over year, with higher EPS from continuing operations. On Aug. 4, 2026, management raised full-year 2026 total sales growth guidance to 4.5% to 5.5% from 3% to 5%, citing stronger momentum.
Recent HSIC coverage spans earnings, financial news and corporate actions.
Guidance lift suggests stronger future earnings, supporting a potential price upside.
Analyst upgrade may prompt short-term buying pressure.
Higher 2026 sales guidance plus stronger Q2 results should support near-term sentiment, but margin risk from competitive pricing remains a key offset.
Guidance raise plus margin expansion and a defined $200 million value-creation target are likely to support near-term earnings expectations.
Guidance increase plus a structural reorg and AI platform rollout can re-rate execution confidence, but near-term impact depends on delivery of the $200M operating improvement plan.
alphai scores every news story that mentions HSIC with an AI model for sentiment and relevance, and aggregates insider trades from HENRY SCHEIN INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Henry Schein, Inc. (HSIC) reported broad-based growth in Q2, with sales increases across distribution, specialty products, and technology. Management raised its 2026 sales and earnings guidance. HSIC trades at a discount to market benchmarks but faces risks from leverage and execution challenges. The company aims for $200M in operating income improvement by 2026, with savings initiatives underway.
3 min readBTIG raised its price target on Henry Schein to $110 from $100 while maintaining a Buy rating. The stock is currently trading at $89.57, up 0.38% on the day but down 1.28% over the past year. Barclays also recently adjusted its target to $100 from $86.
1 min readHenry Schein (HSIC) reported Q2 2026 sales of $3,458 million and net income of $94 million, both up year over year, with higher EPS from continuing operations. On Aug. 4, 2026, management raised full-year 2026 total sales growth guidance to 4.5% to 5.5% from 3% to 5%, citing stronger momentum.
6 min readHenry Schein (HSIC) reported Q2 2026 net sales of $3.5 billion, up 6.7%, and non-GAAP diluted EPS of $1.27. GAAP diluted EPS was $0.82. The company raised 2026 guidance, including non-GAAP EPS to $5.29 to $5.39 and sales growth to 4.5% to 5.5%, and approved $200 million in share repurchases.
6 min readHenry Schein Inc. outlined a transformation focused on AI, simpler leadership, and faster execution in its first earnings report under CEO Fred Lowery. The company reported Q2 net sales of $3.46B (+6.7%) and net income of $94M (+9.3%), raised its 2026 sales outlook to 4.5% to 5.5%, and announced a leadership reorganization integrating supply chain and distribution. It targets $200M+ operating improvements.
7 min readHenry Schein reported Q2 2026 progress including faster internal local-currency sales growth, driven by dental merchandise market-share gains and higher technology platform share. The company raised full-year 2026 sales growth guidance to 4.5% to 5.5% and expects $125 million operating income improvement run rate by end-2026. Restructuring expenses were $29 million.
6 min readCitigroup raised its price target on Henry Schein to $112 from $100, according to the report. UBS also adjusted its target to $94 from $89 and kept a neutral rating. The changes reflect updated analyst views on the stock’s outlook.
1 min readHenry Schein (NASDAQ:HSIC) reported Q2 CY2026 results with revenue up 6.7% year on year to $3.46 billion, exceeding Wall Street estimates by 2.6%, according to the company. Non-GAAP adjusted EPS was $1.27, up from $1.10, beating consensus by 2.5%. Adjusted operating margin was 5.3%. Analysts expect revenue growth of 2.9% over the next 12 months.
3 min readHENRY SCHEIN INC (HSIC) filed an SEC Form 8-K — Results of Operations and Financial Condition. -1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS STRONG SECOND QUARTER 2026 FINANCIAL RESULTS AND RAISES FY2026 GUIDANCE ● Q2 2026 GAAP diluted EPS of $0.82 compared to $0.70 GAAP diluted EPS in Q2 2025 ● Q2 2026 non-GAAP diluted EPS of $1.27 compared to $1.10 non-GAAP diluted
6 min readHenry Schein (HSIC) shares fell 1.8% to $84.25 after the company announced a leadership reorganization. Three senior executives, including COO Michael S. Ettinger, will leave effective Oct. 30, 2026, with a new leadership team and changes to supply chain and distribution. Investors are focused on execution ahead of Q2 results Aug. 4 and a $125 million operating income improvement target by year-end 2026.
3 min read
